»
Current State of Alzheimer's Disease Research and Therapeutics
 
 

Current State of Alzheimer's Disease Research and Therapeutics, 1st Edition

 
Current State of Alzheimer's Disease Research and Therapeutics, 1st Edition,Mary Lou Michaelis,Elias K. Michaelis,ISBN9780123948168
 
 
 

Advances in Pharmacology

Michaelis   &   Michaelis   

Academic Press

9780123948168

9780123948458

400

229 X 152

This new volume of Advances in Pharmacology explores the current state of Alzheimer's disease research and therapeutics. With a variety of chapters and the best authors in the field, the volume is an essential resource for pharmacologists, immunologists and biochemists alike.

Print Book + eBook

USD 303.00
USD 505.00

Buy both together and save 40%

Print Book

Hardcover

In Stock

Estimated Delivery Time
USD 256.00

eBook
eBook Overview

VST format:

DRM Free included formats: EPub, Mobi, PDF

USD 249.00
Add to Cart
 
 

Key Features

  • Explores the current state of Alzheimer's disease research and therapeutics
  • Chapters cover a variety of topics such as the role heat shock proteins play in the Alzheimer's theater, gamma-secretase as a target for Alzheimer's disease, and identification of protein kinase C for the treatment of dementias
  • With the best authors in the field, the volume is an essential resource for pharmacologists, immunologists and biochemists alike

Description

This new volume of Advances in Pharmacology explores the Current State of Alzheimer's Disease Research and Therapeutics. Chapters cover such topics as the The role heat shock proteins play in the Alzheimer's Theater, Gamma-Secretase as a Target for Alzheimer's Disease, and Identification of protein kinase C for the treatment of dementias. With a variety of chapters and the best authors in the field, the volume is an essential resource for pharmacologists, immunologists and biochemists alike.

Readership

Pharmacologists, immunologists, and biochemists

Mary Lou Michaelis

Elias K. Michaelis

Current State of Alzheimer's Disease Research and Therapeutics, 1st Edition

      1. Hsp90 Modulation for the Treatment of Alzheimer’s Disease
      2. Huiping Zhao, Mary L. Michaelis and Brian S. J. Blagg

      3. Using Pittsburgh Compound B for In-vivo PET Imaging of Fibrillar Amyloid-beta
      4. Ann D. Cohen, Gil D. Rabinovici, Chester A. Mathis, William J. Jagust, William E. Klunk and Milos D. Ikonomovic

      5. Mitochondrial Abnormalities in Alzheimer's Disease: Possible Targets for Therapeutic Intervention
      6. Diana F. Silva, J. Eva Selfridge, Jianghua Lu, Lezi E, Sandra M. Cardoso, and Russell H. Swerdlow

      7. g-Secretase as a Target for Alzheimer’s Disease
      8. Michael S. Wolfe

      9. Altering Mitochondrial Dysfunction as an Approach to Treating Alzheimer’s Disease
      10. Jerry R. Colca and Douglas L. Feinstein

      11. scyllo-Inositol, Preclinical and Clinical Data for Alzheimers disease
      12. Keran Ma, Lynsie A.M. Thomason and JoAnne McLaurin

      13. Beyond Amyloid: The Future of Therapeutics for Alzheimer’s Disease
      14. Rachel F Lane, Diana W Shineman, John W Steele, Linda (Bobbi) H Lee and Howard M Fillit

      15. Activation of Protein Kinase C Isozymes for the Treatment of Dementias
      16. Miao-Kun Sun and Daniel L. Alkon

      17. STriatal Enriched Protein Tyrosine Phosphatase in Alzheimer’s Disease
      18. Jian Xu, Pradeep Kurup, Angus C. Nairn and Paul J. Lombroso

      19. Estrogen Regulation of Mitochondrial Bioenergetics: Implications for Prevention of Alzheimer’s Disease

Jia Yao and Roberta Diaz Brinton

 
 

Shop with Confidence

Free Shipping around the world
▪ Broad range of products
▪ 30 days return policy
FAQ

Contact Us